Impact Investing:
Private Debt & Equity Investing in Social Causes

Recently Released!!!
Date Published: May 3, 2017
Summary PPT Deck: 65 Slides
Reference PPT Deck: 730 Slides


The purpose of this research is to provide readers with a comprehensive understanding of impact investing, a growing area of investing. This research combines with Tiburon's research on socially responsible investing to support its broader coverage of socially responsible investing & impact investing, which in turn fits within its wealth management series.

This research addresses the two historical phases of impact investing, including: 
  • Emergergence Phase
  • Maturation Phase

    This research defines a long list of potential investable areas, including:

    • Affordable Housing
    • Clean Technology
    • Community Development Lending
    • Crime & Prison Reform
    • Education & Charter Schools
    • Healthcare
    • Homelessness
    • Job Training
    • Microfinance
    • Pollution Prevention
    • Pro-Environment
    • Repressed Minorities
    • Sustainable Agriculture

    This research addresses the most common investment vehicles, including:

    • Private Debt
    • Private Equity
    • Public Debt
    • Public Equity
    • Other Investment Vehicles

    And this research makes several future predictions for the impact investing market, including:

    • Substantial Impact Investing Market Growth
    • Institutionalization of the Impact Investing Business

Public Access

Please click on the Table of Contents icon below to see more details of this research.

Media Access

Members of the media who would like further access to the components of this research may click on the icon below or send an email to Sarah Sage.


Client Access

Tiburon Research Access Program subscribers and individual research subscribers may click on any of the icons below to access any part of this research.

Tiburon Research Orders

Subscribe

If you are having difficulties subscribing to Tiburon research online please contact Sarah Sage at SSage@TiburonAdvisors.Com or 415-789-2540.